Skip to main content
    A

    Adlai Nortye Ltd. American Depositary Shares (ANL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.03
    -0.58 (-5.47%)

    Market Cap: $683.26M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    20%(1/5)
    Avg Surprise
    -5.90%

    Upcoming Estimates

    Results pendingPeriod ending Sep 30, 2026
    EPS Consensus$0.03
    Range$0.03 - $0.03
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.030.0%
    30d ago$0.030.0%
    7d ago$0.030.0%
    Current$0.03
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.16
    Range-$0.29 - -$0.05
    7 analysts
    Revenue Consensus
    $3.08M
    RangeN/A
    7 analysts
    Last 12 of 17 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    --$0.16-$0.29 - -$0.05--7--
    Sep 26EST
    Date TBD
    -$0.03$0.03 - $0.03--1
    No revisions (30d)
    -
    Jun 26
    Reported Aug 14
    N/A-$0.35-$0.35 - -$0.35--1
    No revisions (30d)
    -
    Mar 26
    Reported Apr 10
    N/AN/AN/A--1
    No revisions (30d)
    -
    Dec 25
    Reported Feb 25
    Not reportedN/AN/A-----
    Sep 25
    Reported Dec 29
    Not reportedN/AN/A-----
    Jun 25
    Reported Aug 7
    -$0.18N/AN/A----+72.2%
    Mar 25
    Reported Apr 30
    -$0.64-$0.63N/A-1.59%Miss0
    No revisions (30d)
    -68.4%
    Sep 24
    Reported Nov 27
    Not reported-$0.62N/A--0
    1
    0
    30d
    -
    Jun 24
    Reported Aug 8
    -$0.35-$0.61N/A+42.62%Beat--+82.0%
    Mar 24
    Reported Apr 20
    -$0.65-$0.38N/A-70.52%Miss---9.7%
    Dec 23
    Reported Mar 30
    -$0.38-$0.38N/A0.00%In line0
    No revisions (30d)
    +56.3%
    Sep 23
    Reported Nov 29
    -$0.24-$0.24N/A0.00%In line0
    No revisions (30d)
    +72.4%
    Jun 23
    Reported Aug 30
    -$1.94N/AN/A-----1313.0%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-124.80%Operating Margin-123.50%
    ROE-20.20%ROIC-7.34%
    Financial Health
    Debt/Equity0.12xInterest CoverageN/A
    Current Ratio9.55xQuick Ratio9.55x
    Trading Statistics
    Beta1.41Avg Volume239.85K
    52-Week High$17.2552-Week Low$0.88

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 22.4% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 42.1, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$10.23
    SMA 20$10.30
    SMA 50$12.92
    SMA 200$11.75
    EMA 10$10.35
    EMA 20$10.72
    EMA 50$11.89
    EMA 200$10.81

    MACD

    Line: -0.64Signal: -0.84Hist: 0.20

    ADX

    ADX: 26.6+DI: 12.5-DI: 19.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down72.0
    PSAR$9.14

    Bollinger Bands

    Upper Band$11.39
    Lower Band$9.21
    %B Position2111%(Upper)
    Band Width0.38

    RSI (14-Day)

    Neutral
    42.1

    Momentum Oscillators

    Stoch %K58.3
    Stoch %D62.6
    Williams %R-55.7
    ROC (10d)7.0%
    Momentum0.66
    CCI (20d)-7.9
    MFI (14d)36.3

    Volatility Measures

    ATR (14d)$1.09(10.9%)
    StdDev (20d)0.54
    Hist Vol81.8%(High)

    Volume Flow

    VWAP$10.27
    OBV50.4M
    AD Line24.4M
    CMF (20d)-0.028

    Volume Metrics

    Avg Vol (20d)234.0K
    Vol Ratio0.7x
    VWMA (20d)$10.27

    Pivot Points

    R3$12.04
    R2$11.48
    R1$11.04
    Pivot Point$10.48
    S1$10.04
    S2$9.48
    S3$9.04

    Advanced Oscillators

    TSI-18.10
    Ultimate Osc52.1
    KST-211.35

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about ANL

    News

    ANL Valuation

    ANL Profitability: Margins, ROIC and FCF

    Adlai Nortye Ltd. American Depositary Shares (ANL) has a gross margin of 100.0%, an operating margin of -123.5% and a net margin of -124.8%. It posts -7.3% ROIC and a -172.1% FCF margin.

    Gross margin
    100.0%
    Operating margin
    -123.5%
    Net margin
    -124.8%
    ROIC
    -7.3%
    ROE
    -20.2%
    FCF margin
    -172.1%
    ANL financial statements

    Adlai Nortye Ltd. American Depositary Shares Competitors

    The companies most similar to Adlai Nortye Ltd. American Depositary Shares (ANL) include Nuvectis Pharma, Ardelyx and Climb Bio.

    Sector: Healthcare

    ANL Analyst Ratings

    Adlai Nortye Ltd. American Depositary Shares (ANL) has a Buy consensus from 7 analysts: 7 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    0
    Buy
    7
    Hold
    0
    Sell
    0
    Strong Sell
    0

    ANL Bull Case vs Bear Case

    Bull case

    • ANL grew quarterly revenue 178.1% year over year.
    • 100.0% of ANL's analyst ratings are Buy or Strong Buy.

    Bear case

    • ANL has a -124.8% net profit margin.

    ANL Earnings: Beat Rate and Next Report

    Beat rate
    1 of 5 quarters (20.0%)
    Average surprise
    -5.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.03
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Updated Oct 22, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About ANL

    Does ANL pay dividends?

    Adlai Nortye Ltd. American Depositary Shares (ANL) does not currently pay a regular dividend.

    What is ANL's market cap?

    Adlai Nortye Ltd. American Depositary Shares (ANL) has a market capitalization of $683.26M with a current stock price of $10.03.

    How do analysts rate ANL stock?

    7 analysts cover Adlai Nortye Ltd. American Depositary Shares (ANL): 0 rate it Strong Buy, 7 Buy, 0 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.

    ANL pages: Overview, Financials

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.